🇺🇸 OLODATEROL HYDROCHLORIDE in United States

3,132 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 584 reports (18.65%)
  2. Wheezing — 485 reports (15.49%)
  3. Asthma — 431 reports (13.76%)
  4. Loss Of Personal Independence In Daily Activities — 259 reports (8.27%)
  5. Pneumonia — 254 reports (8.11%)
  6. Cough — 252 reports (8.05%)
  7. Therapeutic Product Effect Incomplete — 241 reports (7.69%)
  8. Sleep Disorder Due To A General Medical Condition — 227 reports (7.25%)
  9. Chronic Obstructive Pulmonary Disease — 224 reports (7.15%)
  10. Bronchiectasis — 175 reports (5.59%)

Source database →

OLODATEROL HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is OLODATEROL HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for OLODATEROL HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.